<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2018-01-31" version="226">
<accession>P04062</accession>
<accession>A8K796</accession>
<accession>B7Z5G2</accession>
<accession>B7Z6S1</accession>
<accession>J3KQG4</accession>
<accession>J3KQK9</accession>
<accession>Q16545</accession>
<accession>Q4VX22</accession>
<accession>Q6I9R6</accession>
<accession>Q9UMJ8</accession>
<name>GLCM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glucosylceramidase</fullName>
<ecNumber>3.2.1.45</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Acid beta-glucosidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Alglucerase</fullName>
</alternativeName>
<alternativeName>
<fullName>Beta-glucocerebrosidase</fullName>
<shortName>Beta-GC</shortName>
</alternativeName>
<alternativeName>
<fullName>D-glucosyl-N-acylsphingosine glucohydrolase</fullName>
</alternativeName>
<alternativeName>
<fullName>Imiglucerase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GBA</name>
<name type="synonym">GC</name>
<name type="synonym">GLUC</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="7289" last="7293">
<title>Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.</title>
<authorList>
<person name="Sorge J."/>
<person name="West C."/>
<person name="Westwood B."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="3864160"/>
<dbReference type="DOI" id="10.1073/pnas.82.21.7289"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="50" last="53">
<title>Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.</title>
<authorList>
<person name="Tsuji S."/>
<person name="Choudary P.V."/>
<person name="Martin B.M."/>
<person name="Winfield S."/>
<person name="Barranger J.A."/>
<person name="Ginns E.I."/>
</authorList>
<dbReference type="PubMed" id="3001061"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)</scope>
<scope>VARIANT LEU-298</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Genomics" volume="4" first="87" last="96">
<title>The human glucocerebrosidase gene and pseudogene: structure and evolution.</title>
<authorList>
<person name="Horowitz M."/>
<person name="Wilder S."/>
<person name="Horowitz Z."/>
<person name="Reiner O."/>
<person name="Gelbart T."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="2914709"/>
<dbReference type="DOI" id="10.1016/0888-7543(89)90319-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1992" name="Genomics" volume="12" first="795" last="800">
<title>Polymorphisms in the human glucocerebrosidase gene.</title>
<authorList>
<person name="Beutler E."/>
<person name="West C."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="1572652"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90311-F"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Gene" volume="136" first="365" last="368">
<title>A novel transcript from a pseudogene for human glucocerebrosidase in non-Gaucher disease cells.</title>
<authorList>
<person name="Imai K."/>
<person name="Nakamura M."/>
<person name="Yamada M."/>
<person name="Asano A."/>
<person name="Yokoyama S."/>
<person name="Tsuji S."/>
<person name="Ginns E.I."/>
</authorList>
<dbReference type="PubMed" id="8294033"/>
<dbReference type="DOI" id="10.1016/0378-1119(93)90497-Q"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND 3)</scope>
<scope>VARIANTS GD ARG-223; GLY-230; PRO-235; ARG-241; ILE-252 AND ARG-364</scope>
<scope>VARIANTS GLY-310 AND HIS-368</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="1020" last="1026">
<title>Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease.</title>
<authorList>
<person name="Winfield S.L."/>
<person name="Tayebi N."/>
<person name="Martin B.M."/>
<person name="Ginns E.I."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="9331372"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG; 4 AND 5)</scope>
<scope>VARIANT MET-408</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1988" name="DNA" volume="7" first="107" last="116">
<title>Structural analysis of the human glucocerebrosidase genes.</title>
<authorList>
<person name="Reiner O."/>
<person name="Wigderson M."/>
<person name="Horowitz M."/>
</authorList>
<dbReference type="PubMed" id="3359914"/>
<dbReference type="DOI" id="10.1089/dna.1988.7.107"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-11</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1987" name="Am. J. Hum. Genet." volume="41" first="1016" last="1024">
<title>The human glucocerebrosidase gene has two functional ATG initiator codons.</title>
<authorList>
<person name="Sorge J.A."/>
<person name="West C."/>
<person name="Kuhl W."/>
<person name="Treger L."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="3687939"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1984" name="Fed. Proc." volume="43" first="1869" last="1869">
<title>Structural studies of human placental glucocerebrosidase.</title>
<authorList>
<person name="Martin B.M."/>
<person name="Murray G.J."/>
<person name="Coligan J.E."/>
<person name="Raum M."/>
<person name="Brady R.O."/>
<person name="Barranger J.A."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 40-44</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="123" first="574" last="580">
<title>Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system.</title>
<authorList>
<person name="Ginns E.I."/>
<person name="Choudary P.V."/>
<person name="Martin B.M."/>
<person name="Winfield S."/>
<person name="Stubblefield B."/>
<person name="Mayor J."/>
<person name="Merkle-Lehman D."/>
<person name="Murray G.J."/>
<person name="Bowers L.A."/>
<person name="Barranger J.A."/>
</authorList>
<dbReference type="PubMed" id="6091633"/>
<dbReference type="DOI" id="10.1016/0006-291X(84)90268-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 403-416</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="2349" last="2352">
<title>Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.</title>
<authorList>
<person name="Tsuji S."/>
<person name="Martin B.M."/>
<person name="Barranger J.A."/>
<person name="Stubblefield B.K."/>
<person name="LaMarca M.E."/>
<person name="Ginns E.I."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 409-462</scope>
<scope>VARIANT GD1 SER-409</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="1660" last="1664">
<title>Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.</title>
<authorList>
<person name="Dinur T."/>
<person name="Osiecki K.M."/>
<person name="Legler G."/>
<person name="Gatt S."/>
<person name="Desnick R.J."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="3456607"/>
<dbReference type="DOI" id="10.1073/pnas.83.6.1660"/>
</citation>
<scope>PROTEIN SEQUENCE OF 469-520</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="10975" last="10978">
<title>Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry.</title>
<authorList>
<person name="Miao S."/>
<person name="McCarter J.D."/>
<person name="Grace M.E."/>
<person name="Grabowski G.A."/>
<person name="Aebersold R."/>
<person name="Withers S.G."/>
</authorList>
<dbReference type="PubMed" id="7908905"/>
</citation>
<scope>MUTAGENESIS OF GLU-379</scope>
<scope>ACTIVE SITE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="FEBS Lett." volume="472" first="17" last="21">
<title>Further studies on the reconstitution of glucosylceramidase activity by Sap C and anionic phospholipids.</title>
<authorList>
<person name="Salvioli R."/>
<person name="Tatti M."/>
<person name="Ciaffoni F."/>
<person name="Vaccaro A.M."/>
</authorList>
<dbReference type="PubMed" id="10781797"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)01417-4"/>
</citation>
<scope>INTERACTION WITH SAPOSIN-C AND MEMBRANES CONTAINING ANIONIC PHOSPHOLIPIDS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-98; ASN-185 AND ASN-309</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Cell" volume="131" first="770" last="783">
<title>LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.</title>
<authorList>
<person name="Reczek D."/>
<person name="Schwake M."/>
<person name="Schroder J."/>
<person name="Hughes H."/>
<person name="Blanz J."/>
<person name="Jin X."/>
<person name="Brondyk W."/>
<person name="Van Patten S."/>
<person name="Edmunds T."/>
<person name="Saftig P."/>
</authorList>
<dbReference type="PubMed" id="18022370"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.10.018"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SCARB2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Traffic" volume="8" first="1676" last="1686">
<title>Integral and associated lysosomal membrane proteins.</title>
<authorList>
<person name="Schroeder B."/>
<person name="Wrocklage C."/>
<person name="Pan C."/>
<person name="Jaeger R."/>
<person name="Koesters B."/>
<person name="Schaefer H."/>
<person name="Elsaesser H.-P."/>
<person name="Mann M."/>
<person name="Hasilik A."/>
</authorList>
<dbReference type="PubMed" id="17897319"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2007.00643.x"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Brain" volume="132" first="1783" last="1794">
<title>Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.</title>
<authorList>
<person name="Neumann J."/>
<person name="Bras J."/>
<person name="Deas E."/>
<person name="O'Sullivan S.S."/>
<person name="Parkkinen L."/>
<person name="Lachmann R.H."/>
<person name="Li A."/>
<person name="Holton J."/>
<person name="Guerreiro R."/>
<person name="Paudel R."/>
<person name="Segarane B."/>
<person name="Singleton A."/>
<person name="Lees A."/>
<person name="Hardy J."/>
<person name="Houlden H."/>
<person name="Revesz T."/>
<person name="Wood N.W."/>
</authorList>
<dbReference type="PubMed" id="19286695"/>
<dbReference type="DOI" id="10.1093/brain/awp044"/>
</citation>
<scope>INVOLVEMENT IN PARKINSON DISEASE</scope>
<scope>VARIANTS GLU-46; CYS-170; GLU-232; GLN-296; SER-409; ALA-419; HIS-448; ASN-482; PRO-483; PRO-495; LEU-497 AND CYS-502</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98 AND ASN-309</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="EMBO Rep." volume="4" first="704" last="709">
<title>X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.</title>
<authorList>
<person name="Dvir H."/>
<person name="Harel M."/>
<person name="McCarthy A.A."/>
<person name="Toker L."/>
<person name="Silman I."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="12792654"/>
<dbReference type="DOI" id="10.1038/sj.embor.embor873"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 40-536</scope>
<scope>GLYCOSYLATION AT ASN-58</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="23815" last="23819">
<title>X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.</title>
<authorList>
<person name="Premkumar L."/>
<person name="Sawkar A.R."/>
<person name="Boldin-Adamsky S."/>
<person name="Toker L."/>
<person name="Silman I."/>
<person name="Kelly J.W."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="15817452"/>
<dbReference type="DOI" id="10.1074/jbc.M502799200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 40-536 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="4242" last="4253">
<title>Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.</title>
<authorList>
<person name="Liou B."/>
<person name="Kazimierczuk A."/>
<person name="Zhang M."/>
<person name="Scott C.R."/>
<person name="Hegde R.S."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="16293621"/>
<dbReference type="DOI" id="10.1074/jbc.M511110200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 40-536</scope>
<scope>CHARACTERIZATION OF VARIANTS GD SER-55; GLN-87; ASN-118; GLN-159; LEU-161; VAL-162; VAL-166; ASN-200; PHE-213; PHE-224; GLU-232; GLU-237; LEU-298; ILE-303; CYS-343; ILE-362; LYS-365; GLY-381; LYS-388; TRP-392; CYS-402; SER-409; VAL-410; HIS-419; LYS-421; ARG-429; LEU-433; SER-436; ASN-438; HIS-448; VAL-455; PRO-483; PRO-500 AND PRO-502</scope>
<scope>MUTAGENESIS OF CYS-43; CYS-57 AND CYS-62</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Acta Crystallogr. D" volume="62" first="1458" last="1465">
<title>Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease.</title>
<authorList>
<person name="Brumshtein B."/>
<person name="Wormald M.R."/>
<person name="Silman I."/>
<person name="Futerman A.H."/>
<person name="Sussman J.L."/>
</authorList>
<dbReference type="PubMed" id="17139081"/>
<dbReference type="DOI" id="10.1107/S0907444906038303"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 40-536</scope>
<scope>GLYCOSYLATION AT ASN-58; ASN-98 AND ASN-185</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Nat. Chem. Biol." volume="3" first="101" last="107">
<title>Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.</title>
<authorList>
<person name="Lieberman R.L."/>
<person name="Wustman B.A."/>
<person name="Huertas P."/>
<person name="Powe A.C. Jr."/>
<person name="Pine C.W."/>
<person name="Khanna R."/>
<person name="Schlossmacher M.G."/>
<person name="Ringe D."/>
<person name="Petsko G.A."/>
</authorList>
<dbReference type="PubMed" id="17187079"/>
<dbReference type="DOI" id="10.1038/nchembio850"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 40-536 IN COMPLEXES WITH ISOFAGOMINE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="3" first="1" last="11">
<title>Mutations causing Gaucher disease.</title>
<authorList>
<person name="Horowitz M."/>
<person name="Zimran A."/>
</authorList>
<dbReference type="PubMed" id="8118460"/>
<dbReference type="DOI" id="10.1002/humu.1380030102"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="207" last="213">
<title>Glucocerebrosidase (Gaucher disease).</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8889578"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:3&lt;207::AID-HUMU2>3.3.CO;2-5"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1999" name="Mol. Genet. Metab." volume="68" first="209" last="219">
<title>Type 2 Gaucher disease: an expanding phenotype.</title>
<authorList>
<person name="Tayebi N."/>
<person name="Stone D.L."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10527671"/>
<dbReference type="DOI" id="10.1006/mgme.1999.2918"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="181" last="188">
<title>Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.</title>
<authorList>
<person name="Stone D.L."/>
<person name="Tayebi N."/>
<person name="Orvisky E."/>
<person name="Stubblefield B."/>
<person name="Madike V."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10649495"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200002)15:2&lt;181::AID-HUMU7>3.3.CO;2-J"/>
</citation>
<scope>REVIEW ON GD VARIANTS</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1990" name="Ann. Hum. Genet." volume="54" first="149" last="153">
<title>Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="1974409"/>
<dbReference type="DOI" id="10.1111/j.1469-1809.1990.tb00371.x"/>
</citation>
<scope>VARIANT GD TYR-255</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1990" name="DNA Cell Biol." volume="9" first="233" last="241">
<title>Sequence of two alleles responsible for Gaucher disease.</title>
<authorList>
<person name="Hong C.M."/>
<person name="Ohashi T."/>
<person name="Yu X.J."/>
<person name="Weiler S."/>
<person name="Barranger J.A."/>
</authorList>
<dbReference type="PubMed" id="1972019"/>
<dbReference type="DOI" id="10.1089/dna.1990.9.233"/>
</citation>
<scope>VARIANT GD CYS-502</scope>
<scope>CHARACTERIZATION OF VARIANT GD CYS-502</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1993" name="Genomics" volume="15" first="203" last="205">
<title>Identification of six new Gaucher disease mutations.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
<person name="West C."/>
</authorList>
<dbReference type="PubMed" id="8432537"/>
<dbReference type="DOI" id="10.1006/geno.1993.1035"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1994" name="Am. J. Med. Genet." volume="51" first="156" last="160">
<title>DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wei C."/>
<person name="Applegarth D.A."/>
<person name="McGillivray B.C."/>
</authorList>
<dbReference type="PubMed" id="7916532"/>
<dbReference type="DOI" id="10.1002/ajmg.1320510216"/>
</citation>
<scope>VARIANT GD HIS-535</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1994" name="Hum. Genet." volume="93" first="209" last="210">
<title>Two new Gaucher disease mutations.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8112750"/>
<dbReference type="DOI" id="10.1007/BF00210614"/>
</citation>
<scope>VARIANT GD ASN-438</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1994" name="Hum. Genet." volume="94" first="314" last="315">
<title>Y418C: a novel mutation in exon 9 of the glucocerebrosidase gene of a patient with Gaucher disease creates a new Bgl I site.</title>
<authorList>
<person name="Tuteja R."/>
<person name="Tuteja N."/>
<person name="Lilliu F."/>
<person name="Bembi B."/>
<person name="Galanello R."/>
<person name="Cao A."/>
<person name="Baralle F.E."/>
</authorList>
<dbReference type="PubMed" id="8076951"/>
<dbReference type="DOI" id="10.1007/BF00208292"/>
</citation>
<scope>VARIANTS GD SER-409 AND CYS-457</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1994" name="Mol. Med." volume="1" first="82" last="92">
<title>Glucocerebrosidase mutations in Gaucher disease.</title>
<authorList>
<person name="Beutler E."/>
<person name="Demina A."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="8790604"/>
</citation>
<scope>VARIANTS GD ASP-215; THR-221; ARG-241; GLN-296; CYS-324; GLY-417 AND ASN-419</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="303" last="309">
<title>Gaucher disease in Spanish patients: analysis of eight mutations.</title>
<authorList>
<person name="Cormand B."/>
<person name="Vilageliu L."/>
<person name="Burguera J.M."/>
<person name="Balcells S."/>
<person name="Gonzalez-Duarte R."/>
<person name="Grinberg D."/>
<person name="Chabas A."/>
</authorList>
<dbReference type="PubMed" id="7627184"/>
<dbReference type="DOI" id="10.1002/humu.1380050406"/>
</citation>
<scope>VARIANTS GD SER-409; HIS-448; PRO-483 AND CYS-502</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="345" last="347">
<title>Identification of a new mutation (P178S) in an African-American patient with type 2 Gaucher disease.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wei C."/>
</authorList>
<dbReference type="PubMed" id="7627192"/>
<dbReference type="DOI" id="10.1002/humu.1380050414"/>
</citation>
<scope>VARIANT GD SER-217</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1996" name="Clin. Genet." volume="50" first="78" last="84">
<title>The molecular characterization of Gaucher disease in South Africa.</title>
<authorList>
<person name="Morar B."/>
<person name="Lane A.B."/>
</authorList>
<dbReference type="PubMed" id="8937765"/>
</citation>
<scope>VARIANTS GD SER-409; LEU-426; LEU-433 AND PRO-483</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="214" last="218">
<title>Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations.</title>
<authorList>
<person name="Kim J.-W."/>
<person name="Liou B.B."/>
<person name="Lai M.-Y."/>
<person name="Ponce E."/>
<person name="Grabowski G.A."/>
</authorList>
<dbReference type="PubMed" id="8829654"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:3&lt;214::AID-HUMU5>3.0.CO;2-A"/>
</citation>
<scope>VARIANTS GD LEU-54; GLU-85 AND SER-227</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="272" last="274">
<title>Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients.</title>
<authorList>
<person name="Cormand B."/>
<person name="Vilageliu L."/>
<person name="Balcells S."/>
<person name="Gonzalez-Duatre R."/>
<person name="Chabas A."/>
<person name="Grinberg D."/>
</authorList>
<dbReference type="PubMed" id="8829663"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:3&lt;272::AID-HUMU14>3.3.CO;2-7"/>
</citation>
<scope>VARIANTS GD HIS-352 AND GLN-398</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="280" last="281">
<title>Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.</title>
<authorList>
<person name="Amaral O."/>
<person name="Pinto E."/>
<person name="Fortuna M."/>
<person name="Lacerda L."/>
<person name="Sa Miranda M.C."/>
</authorList>
<dbReference type="PubMed" id="8889591"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:3&lt;280::AID-HUMU15>3.3.CO;2-6"/>
</citation>
<scope>VARIANT GD1 THR-435</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1996" name="Neurology" volume="46" first="1102" last="1107">
<title>Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease.</title>
<authorList>
<person name="Seeman P.J.V."/>
<person name="Finckh U."/>
<person name="Hoeppner J."/>
<person name="Lakner V."/>
<person name="Liebisch I."/>
<person name="Grau G."/>
<person name="Rolfs A."/>
</authorList>
<dbReference type="PubMed" id="8780099"/>
<dbReference type="DOI" id="10.1212/WNL.46.4.1102"/>
</citation>
<scope>VARIANTS GD3 LEU-437 AND ILE-530</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1997" name="Am. J. Med. Genet." volume="70" first="437" last="443">
<title>Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses.</title>
<authorList>
<person name="Cormand B."/>
<person name="Grinberg D."/>
<person name="Gort L."/>
<person name="Fiumara A."/>
<person name="Barone R."/>
<person name="Vilageliu L."/>
<person name="Chabas A."/>
</authorList>
<dbReference type="PubMed" id="9182788"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19970627)70:4&lt;437::AID-AJMG19>3.0.CO;2-I"/>
</citation>
<scope>VARIANTS GD LEU-414 AND THR-441</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1997" name="Am. J. Med. Genet." volume="71" first="172" last="178">
<title>Identification of two novel and four uncommon missense mutations among Chinese Gaucher disease patients.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Shi H."/>
</authorList>
<dbReference type="PubMed" id="9217217"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19970808)71:2&lt;172::AID-AJMG10>3.0.CO;2-B"/>
</citation>
<scope>VARIANTS GD VAL-76; GLU-85; TRP-87; TRP-159; SER-227; ILE-252 AND PRO-483</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1997" name="Arch. Dis. Child." volume="77" first="17" last="22">
<title>Mutation analysis in 46 British and Irish patients with Gaucher's disease.</title>
<authorList>
<person name="Hatton C.E."/>
<person name="Cooper A."/>
<person name="Whitehouse C."/>
<person name="Wraith J.E."/>
</authorList>
<dbReference type="PubMed" id="9279145"/>
<dbReference type="DOI" id="10.1136/adc.77.1.17"/>
</citation>
<scope>VARIANT GD LYS-501</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1997" name="J. Clin. Invest." volume="99" first="2530" last="2537">
<title>Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.</title>
<authorList>
<person name="Grace M.E."/>
<person name="Desnick R.J."/>
<person name="Pastores G.M."/>
</authorList>
<dbReference type="PubMed" id="9153297"/>
<dbReference type="DOI" id="10.1172/JCI119437"/>
</citation>
<scope>VARIANTS GD TRP-87; GLU-234; ARG-241; ILE-252; ASN-310; LEU-391 AND SER-409</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1997" name="J. Inherit. Metab. Dis." volume="20" first="67" last="73">
<title>Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations.</title>
<authorList>
<person name="Ida H."/>
<person name="Rennert O.M."/>
<person name="Kawame H."/>
<person name="Maekawa K."/>
<person name="Eto Y."/>
</authorList>
<dbReference type="PubMed" id="9061570"/>
<dbReference type="DOI" id="10.1023/A:1005313724361"/>
</citation>
<scope>VARIANTS GD VAL-228; ILE-252; GLY-405; HIS-448; GLN-452; PRO-483 AND CYS-535</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1997" name="J. Med. Genet." volume="34" first="175" last="175">
<title>D409H/D409H genotype in Gaucher-like disease.</title>
<authorList>
<person name="Uyama E."/>
<person name="Uchino M."/>
<person name="Ida H."/>
<person name="Eto Y."/>
<person name="Owada M."/>
</authorList>
<dbReference type="PubMed" id="9040001"/>
<dbReference type="DOI" id="10.1136/jmg.34.2.175"/>
</citation>
<scope>VARIANT PSEUDO-GAUCHER HIS-448</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Acta Haematol." volume="99" first="80" last="82">
<title>Six new Gaucher disease mutations.</title>
<authorList>
<person name="Demina A."/>
<person name="Beutler E."/>
</authorList>
<dbReference type="PubMed" id="9554454"/>
<dbReference type="DOI" id="10.1159/000040815"/>
</citation>
<scope>VARIANTS GD LEU-146; LEU-198; THR-380; ASN-405 AND ARG-432</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="63" first="415" last="427">
<title>Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.</title>
<authorList>
<person name="Germain D.P."/>
<person name="Puech J.-P."/>
<person name="Caillaud C."/>
<person name="Kahn A."/>
<person name="Poenaru L."/>
</authorList>
<dbReference type="PubMed" id="9683600"/>
<dbReference type="DOI" id="10.1086/301969"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="78" first="92" last="93">
<title>Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Ben-Yoseph Y."/>
</authorList>
<dbReference type="PubMed" id="9637431"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980616)78:1&lt;92::AID-AJMG19>3.0.CO;2-J"/>
</citation>
<scope>VARIANT GD2 TYR-513</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="Blood Cells Mol. Dis." volume="24" first="2" last="8">
<title>Hematologically important mutations: Gaucher disease.</title>
<authorList>
<person name="Beutler E."/>
<person name="Gelbart T."/>
</authorList>
<dbReference type="PubMed" id="9516376"/>
<dbReference type="DOI" id="10.1006/bcmd.1998.0165"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1998" name="Blood Cells Mol. Dis." volume="24" first="420" last="427">
<title>A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.</title>
<authorList>
<person name="Sinclair G."/>
<person name="Choy F.Y.M."/>
<person name="Humphries L."/>
</authorList>
<dbReference type="PubMed" id="9851895"/>
<dbReference type="DOI" id="10.1006/bcmd.1998.0210"/>
</citation>
<scope>VARIANTS GD2 LYS-80; CYS-170 AND PRO-483</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1998" name="Clin. Genet." volume="53" first="281" last="285">
<title>A novel mutation of the beta-glucocerebrosidase gene associated with neurologic manifestations in three sibs.</title>
<authorList>
<person name="Parenti G."/>
<person name="Filocamo M."/>
<person name="Titomanlio L."/>
<person name="Rizzolo G."/>
<person name="Silvestro E."/>
<person name="Perretti A."/>
<person name="Gatti R."/>
<person name="Andria G."/>
</authorList>
<dbReference type="PubMed" id="9650766"/>
</citation>
<scope>VARIANT GD GLY-392</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="295" last="305">
<title>Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.</title>
<authorList>
<person name="Cormand B."/>
<person name="Grinberg D."/>
<person name="Gort L."/>
<person name="Chabas A."/>
<person name="Vilageliu L."/>
</authorList>
<dbReference type="PubMed" id="9554746"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:4&lt;295::AID-HUMU7>3.0.CO;2-6"/>
</citation>
<scope>VARIANTS GD GLU-152; PRO-173; GLU-428; LEU-430; ILE-431 AND HIS-451</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="411" last="412">
<title>A novel mutation (V191G) in a German-British type 1 Gaucher disease patient.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Humphries M.L."/>
<person name="Ben-Yoseph Y."/>
</authorList>
<dbReference type="PubMed" id="10206680"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:5&lt;411::AID-HUMU13>3.0.CO;2-X"/>
</citation>
<scope>VARIANTS GD1 GLY-230 AND SER-409</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="84" first="334" last="339">
<title>Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.</title>
<authorList>
<person name="Wasserstein M.P."/>
<person name="Martignetti J.A."/>
<person name="Zeitlin R."/>
<person name="Lumerman H."/>
<person name="Solomon M."/>
<person name="Grace M.E."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="10340647"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19990604)84:4&lt;334::AID-AJMG5>3.3.CO;2-G"/>
</citation>
<scope>VARIANTS GD1 SER-409 AND LEU-440</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="84" first="484" last="486">
<title>Glucocerebrosidase mutations among Chinese neuronopathic and non-neuronopathic Gaucher disease patients.</title>
<authorList>
<person name="Choy F.Y.M."/>
<person name="Wong K."/>
<person name="Shi H.P."/>
</authorList>
<dbReference type="PubMed" id="10360404"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19990611)84:5&lt;484::AID-AJMG14>3.0.CO;2-W"/>
</citation>
<scope>VARIANTS GD ARG-241; CYS-244; ILE-252; HIS-448 AND PRO-483</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1999" name="Blood Cells Mol. Dis." volume="25" first="287" last="298">
<title>Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles.</title>
<authorList>
<person name="Hodanov K."/>
<person name="Hrebicek M."/>
<person name="Cervenkov M."/>
<person name="Mrzov L."/>
<person name="Veprekov L."/>
<person name="Zemen J."/>
</authorList>
<dbReference type="PubMed" id="10744424"/>
</citation>
<scope>VARIANTS GD</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1999" name="Eur. J. Hum. Genet." volume="7" first="505" last="509">
<title>Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?</title>
<authorList>
<person name="Stone D.L."/>
<person name="van Diggelen O.P."/>
<person name="de Klerk J.B.C."/>
<person name="Gaillard J.L.J."/>
<person name="Niermeijer M.F."/>
<person name="Willemsen R."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10352942"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200315"/>
</citation>
<scope>VARIANTS PERINATAL LETHAL GD ARG-350 AND PHE-437</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="88" last="88">
<title>Detection of three rare (G377S, T134P and 1451delAC), and two novel mutations (G195W and Rec[1263del55;1342G>C]] in Spanish Gaucher disease patients.</title>
<authorList>
<person name="Sarria A.J."/>
<person name="Giraldo P."/>
<person name="Perez-Calvo J.I."/>
<person name="Pocovi M."/>
</authorList>
<dbReference type="PubMed" id="10447266"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)14:1&lt;88::AID-HUMU16>3.0.CO;2-E"/>
</citation>
<scope>VARIANTS GD PRO-173; TRP-234; SER-409; SER-416; HIS-448 AND PRO-483</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="1777" last="1786">
<title>Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.</title>
<authorList>
<person name="Koprivica V."/>
<person name="Stone D.L."/>
<person name="Park J.K."/>
<person name="Callahan M."/>
<person name="Frisch A."/>
<person name="Cohen I.J."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="10796875"/>
<dbReference type="DOI" id="10.1086/302925"/>
</citation>
<scope>VARIANTS GD TRP-87; ASN-118; THR-129; ASP-156; GLN-159; TRP-159; LEU-170; ILE-173; CYS-209; PRO-209; SER-227; THR-229; PRO-235; ARG-241; ILE-252; GLN-296; CYS-324; THR-380; MET-408; SER-409; SER-416; LEU-433; TYR-438; HIS-448; PRO-483 AND CYS-502</scope>
<scope>VARIANT LYS-365</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="109" first="328" last="331">
<title>Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S).</title>
<authorList>
<person name="Bodamer O.A.F."/>
<person name="Church H.J."/>
<person name="Cooper A."/>
<person name="Wraith J.E."/>
<person name="Scott C.R."/>
<person name="Scaglia F."/>
</authorList>
<dbReference type="PubMed" id="11992489"/>
<dbReference type="DOI" id="10.1002/ajmg.10385"/>
</citation>
<scope>VARIANTS GD SER-55 AND HIS-448</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="19" first="458" last="459">
<title>The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.</title>
<authorList>
<person name="Orvisky E."/>
<person name="Park J.K."/>
<person name="Parker A."/>
<person name="Walker J.M."/>
<person name="Martin B.M."/>
<person name="Stubblefield B.K."/>
<person name="Uyama E."/>
<person name="Tayebi N."/>
<person name="Sidransky E."/>
</authorList>
<dbReference type="PubMed" id="11933202"/>
<dbReference type="DOI" id="10.1002/humu.9024"/>
</citation>
<scope>VARIANTS GD GLU-175; PRO-201; GLU-237; LEU-290 AND PHE-441</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="234" last="235">
<title>Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients.</title>
<authorList>
<person name="Filocamo M."/>
<person name="Mazzotti R."/>
<person name="Stroppiano M."/>
<person name="Seri M."/>
<person name="Giona F."/>
<person name="Parenti G."/>
<person name="Regis S."/>
<person name="Corsolini F."/>
<person name="Zoboli S."/>
<person name="Gatti R."/>
</authorList>
<dbReference type="PubMed" id="12204005"/>
<dbReference type="DOI" id="10.1002/humu.9058"/>
</citation>
<scope>VARIANTS GD THR-198; ARG-241; ARG-270; ILE-400 AND ARG-490</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2003" name="Neurology" volume="61" first="99" last="101">
<title>Gaucher's disease with Parkinson's disease: clinical and pathological aspects.</title>
<authorList>
<person name="Bembi B."/>
<person name="Zambito Marsala S."/>
<person name="Sidransky E."/>
<person name="Ciana G."/>
<person name="Carrozzi M."/>
<person name="Zorzon M."/>
<person name="Martini C."/>
<person name="Gioulis M."/>
<person name="Pittis M.G."/>
<person name="Capus L."/>
</authorList>
<dbReference type="PubMed" id="12847165"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000072482.70963.D7"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN PARKINSON DISEASE</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2004" name="Eur. J. Hum. Genet." volume="12" first="975" last="978">
<title>Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.</title>
<authorList>
<person name="Church H.J."/>
<person name="Cooper A."/>
<person name="Stewart F."/>
<person name="Thornton C.M."/>
<person name="Wraith J.E."/>
</authorList>
<dbReference type="PubMed" id="15292921"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201251"/>
</citation>
<scope>VARIANT GD SER-55</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2005" name="Biochem. J." volume="390" first="95" last="103">
<title>The N370S (Asn370->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.</title>
<authorList>
<person name="Salvioli R."/>
<person name="Tatti M."/>
<person name="Scarpa S."/>
<person name="Moavero S.M."/>
<person name="Ciaffoni F."/>
<person name="Felicetti F."/>
<person name="Kaneski C.R."/>
<person name="Brady R.O."/>
<person name="Vaccaro A.M."/>
</authorList>
<dbReference type="PubMed" id="15826241"/>
<dbReference type="DOI" id="10.1042/BJ20050325"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GD SER-409</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="100" last="100">
<title>Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1.</title>
<authorList>
<person name="Miocic S."/>
<person name="Filocamo M."/>
<person name="Dominissini S."/>
<person name="Montalvo A.L."/>
<person name="Vlahovicek K."/>
<person name="Deganuto M."/>
<person name="Mazzotti R."/>
<person name="Cariati R."/>
<person name="Bembi B."/>
<person name="Pittis M.G."/>
</authorList>
<dbReference type="PubMed" id="15605411"/>
<dbReference type="DOI" id="10.1002/humu.9301"/>
</citation>
<scope>VARIANTS GD1 ASN-63; SER-158; TRP-159; CYS-170; LEU-221; GLU-230; ARG-241; GLN-294; CYS-324; SER-409; ASN-438; LEU-440; HIS-448; CYS-457; ASP-460; PRO-483 AND ARG-490</scope>
<scope>CHARACTERIZATION OF VARIANTS GD1 ASN-63; SER-158; LEU-221; GLU-230 AND ASP-460</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2005" name="Neurology" volume="65" first="1460" last="1461">
<title>Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.</title>
<authorList>
<person name="Aharon-Peretz J."/>
<person name="Badarny S."/>
<person name="Rosenbaum H."/>
<person name="Gershoni-Baruch R."/>
</authorList>
<dbReference type="PubMed" id="16148263"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000176987.47875.28"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN PARKINSON DISEASE</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Arch. Neurol." volume="64" first="1056" last="1058">
<title>Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients.</title>
<authorList>
<person name="Tan E.K."/>
<person name="Tong J."/>
<person name="Fook-Chong S."/>
<person name="Yih Y."/>
<person name="Wong M.C."/>
<person name="Pavanni R."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="17620502"/>
<dbReference type="DOI" id="10.1001/archneur.64.7.1056"/>
</citation>
<scope>INVOLVEMENT OF VARIANT GD PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2008" name="Arch. Neurol." volume="65" first="379" last="382">
<title>Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.</title>
<authorList>
<person name="Mata I.F."/>
<person name="Samii A."/>
<person name="Schneer S.H."/>
<person name="Roberts J.W."/>
<person name="Griffith A."/>
<person name="Leis B.C."/>
<person name="Schellenberg G.D."/>
<person name="Sidransky E."/>
<person name="Bird T.D."/>
<person name="Leverenz J.B."/>
<person name="Tsuang D."/>
<person name="Zabetian C.P."/>
</authorList>
<dbReference type="PubMed" id="18332251"/>
<dbReference type="DOI" id="10.1001/archneurol.2007.68"/>
</citation>
<scope>INVOLVEMENT OF VARIANTS GD SER-409 AND PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="361" first="1651" last="1661">
<title>Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.</title>
<authorList>
<person name="Sidransky E."/>
<person name="Nalls M.A."/>
<person name="Aasly J.O."/>
<person name="Aharon-Peretz J."/>
<person name="Annesi G."/>
<person name="Barbosa E.R."/>
<person name="Bar-Shira A."/>
<person name="Berg D."/>
<person name="Bras J."/>
<person name="Brice A."/>
<person name="Chen C.M."/>
<person name="Clark L.N."/>
<person name="Condroyer C."/>
<person name="De Marco E.V."/>
<person name="Durr A."/>
<person name="Eblan M.J."/>
<person name="Fahn S."/>
<person name="Farrer M.J."/>
<person name="Fung H.C."/>
<person name="Gan-Or Z."/>
<person name="Gasser T."/>
<person name="Gershoni-Baruch R."/>
<person name="Giladi N."/>
<person name="Griffith A."/>
<person name="Gurevich T."/>
<person name="Januario C."/>
<person name="Kropp P."/>
<person name="Lang A.E."/>
<person name="Lee-Chen G.J."/>
<person name="Lesage S."/>
<person name="Marder K."/>
<person name="Mata I.F."/>
<person name="Mirelman A."/>
<person name="Mitsui J."/>
<person name="Mizuta I."/>
<person name="Nicoletti G."/>
<person name="Oliveira C."/>
<person name="Ottman R."/>
<person name="Orr-Urtreger A."/>
<person name="Pereira L.V."/>
<person name="Quattrone A."/>
<person name="Rogaeva E."/>
<person name="Rolfs A."/>
<person name="Rosenbaum H."/>
<person name="Rozenberg R."/>
<person name="Samii A."/>
<person name="Samaddar T."/>
<person name="Schulte C."/>
<person name="Sharma M."/>
<person name="Singleton A."/>
<person name="Spitz M."/>
<person name="Tan E.K."/>
<person name="Tayebi N."/>
<person name="Toda T."/>
<person name="Troiano A.R."/>
<person name="Tsuji S."/>
<person name="Wittstock M."/>
<person name="Wolfsberg T.G."/>
<person name="Wu Y.R."/>
<person name="Zabetian C.P."/>
<person name="Zhao Y."/>
<person name="Ziegler S.G."/>
</authorList>
<dbReference type="PubMed" id="19846850"/>
<dbReference type="DOI" id="10.1056/NEJMoa0901281"/>
</citation>
<scope>INVOLVEMENT OF VARIANTS GD SER-409 AND PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2016" name="Ann. Neurol." volume="79" first="244" last="256">
<title>DNAJC6 mutations associated with early-onset Parkinson's disease.</title>
<authorList>
<consortium name="International Parkinsonism Genetics Network"/>
<person name="Olgiati S."/>
<person name="Quadri M."/>
<person name="Fang M."/>
<person name="Rood J.P."/>
<person name="Saute J.A."/>
<person name="Chien H.F."/>
<person name="Bouwkamp C.G."/>
<person name="Graafland J."/>
<person name="Minneboo M."/>
<person name="Breedveld G.J."/>
<person name="Zhang J."/>
<person name="Verheijen F.W."/>
<person name="Boon A.J."/>
<person name="Kievit A.J."/>
<person name="Jardim L.B."/>
<person name="Mandemakers W."/>
<person name="Barbosa E.R."/>
<person name="Rieder C.R."/>
<person name="Leenders K.L."/>
<person name="Wang J."/>
<person name="Bonifati V."/>
</authorList>
<dbReference type="PubMed" id="26528954"/>
<dbReference type="DOI" id="10.1002/ana.24553"/>
</citation>
<scope>VARIANT PRO-363</scope>
</reference>
<comment type="catalytic activity">
<text>D-glucosyl-N-acylsphingosine + H(2)O = D-glucose + N-acylsphingosine.</text>
</comment>
<comment type="enzyme regulation">
<text>Requires saposin-C and anionic phospholipids for activity.</text>
</comment>
<comment type="subunit">
<text evidence="14 25 33">Interacts with saposin-C. Interacts with SCARB2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1564609"/>
<interactant intactId="EBI-356553">
<id>P17987</id>
<label>TCP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="30 32 33">Lysosome membrane</location>
<topology evidence="30 32 33">Peripheral membrane protein</topology>
<orientation evidence="30 32 33">Lumenal side</orientation>
</subcellularLocation>
<text>Interaction with saposin-C promotes membrane association. Targeting to lysosomes occurs through an alternative MPR-independent mechanism via SCARB2.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P04062-1</id>
<name>Long</name>
<sequence type="displayed"/>
<text>Has a 39 residue signal sequence. The upstream initiation site produces two to three times as much protein as does the downstream initiation codon.</text>
</isoform>
<isoform>
<id>P04062-2</id>
<name>Short</name>
<sequence type="described" ref="VSP_018800"/>
<text>Has a 19 residue signal sequence.</text>
</isoform>
<isoform>
<id>P04062-3</id>
<name>3</name>
<sequence type="described" ref="VSP_025216 VSP_025217 VSP_025218"/>
<text>Produced by alternative splicing.</text>
</isoform>
<isoform>
<id>P04062-4</id>
<name>4</name>
<sequence type="described" ref="VSP_054655"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P04062-5</id>
<name>5</name>
<sequence type="described" ref="VSP_054656"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="disease" evidence="10 11 12 13 15 16 17 18 23 26 28 31 34 37 38 39 42 43 45 46 47 48 49 51 52 53 55 57 58 59 60 61 62 63 64 66 67">
<disease id="DI-03092">
<name>Gaucher disease</name>
<acronym>GD</acronym>
<description>A lysosomal storage disease due to deficient activity of beta-glucocerebrosidase and characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Different clinical forms are recognized depending on the presence (neuronopathic forms) or absence of central nervous system involvement, severity and age of onset.</description>
<dbReference type="MIM" id="230800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="8 9 24 54 70">
<disease id="DI-01647">
<name>Gaucher disease 1</name>
<acronym>GD1</acronym>
<description>A form of Gaucher disease characterized by hepatosplenomegaly with consequent anemia and thrombopenia, and bone involvement. The central nervous system is not involved.</description>
<dbReference type="MIM" id="230800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="65 68">
<disease id="DI-01648">
<name>Gaucher disease 2</name>
<acronym>GD2</acronym>
<description>The most severe form of Gaucher disease. It manifests soon after birth, with death generally occurring before patients reach two years of age.</description>
<dbReference type="MIM" id="230900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="50">
<disease id="DI-01649">
<name>Gaucher disease 3</name>
<acronym>GD3</acronym>
<description>A subacute form of neuronopathic Gaucher disease. It has later onset and slower progression compared to the acute form of neuronopathic Gaucher disease 2.</description>
<dbReference type="MIM" id="231000"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01650">
<name>Gaucher disease 3C</name>
<acronym>GD3C</acronym>
<description>A variant of subacute neuronopathic Gaucher disease 3 associated with cardiovascular calcifications.</description>
<dbReference type="MIM" id="231005"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02151">
<name>Gaucher disease perinatal lethal</name>
<acronym>GDPL</acronym>
<description>Distinct form of Gaucher disease type 2, characterized by fetal onset. Hydrops fetalis, in utero fetal death and neonatal distress are prominent features. When hydrops is absent, neurologic involvement begins in the first week and leads to death within 3 months. Hepatosplenomegaly is a major sign, and is associated with ichthyosis, arthrogryposis, and facial dysmorphism.</description>
<dbReference type="MIM" id="608013"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Perinatal lethal Gaucher disease is associated with non-immune hydrops fetalis, a generalized edema of the fetus with fluid accumulation in the body cavities due to non-immune causes. Non-immune hydrops fetalis is not a diagnosis in itself but a symptom, a feature of many genetic disorders, and the end-stage of a wide variety of disorders.</text>
</comment>
<comment type="disease" evidence="21 27 36">
<disease id="DI-02134">
<name>Parkinson disease</name>
<acronym>PARK</acronym>
<description>A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.</description>
<dbReference type="MIM" id="168600"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="pharmaceutical">
<text>Available under the names Ceredase and Cerezyme (Genzyme). Used to treat Gaucher's disease.</text>
</comment>
<comment type="similarity">
<text evidence="75">Belongs to the glycosyl hydrolase 30 family.</text>
</comment>
<comment type="online information" name="Ceredase">
<link uri="https://www.rxlist.com/ceredase-drug.htm"/>
<text>Clinical information on Ceredase</text>
</comment>
<comment type="online information" name="Cerezyme">
<link uri="https://www.rxlist.com/cerezyme-drug.htm"/>
<text>Clinical information on Cerezyme</text>
</comment>
<dbReference type="EC" id="3.2.1.45"/>
<dbReference type="EMBL" id="M16328">
<property type="protein sequence ID" value="AAA35873.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02920">
<property type="protein sequence ID" value="AAA35877.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J03059">
<property type="protein sequence ID" value="AAC63056.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D13286">
<property type="protein sequence ID" value="BAA02545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13287">
<property type="protein sequence ID" value="BAA02546.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF023268">
<property type="protein sequence ID" value="AAC51820.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291911">
<property type="protein sequence ID" value="BAF84600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298900">
<property type="protein sequence ID" value="BAH12898.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300829">
<property type="protein sequence ID" value="BAH13357.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713999">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003356">
<property type="protein sequence ID" value="AAH03356.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M19285">
<property type="protein sequence ID" value="AAA35880.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M18916">
<property type="protein sequence ID" value="AAA35878.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M18917">
<property type="protein sequence ID" value="AAA35879.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20248">
<property type="protein sequence ID" value="AAA35874.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20282">
<property type="protein sequence ID" value="AAA35876.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1102.1">
<molecule id="P04062-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53373.1">
<molecule id="P04062-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53374.1">
<molecule id="P04062-5"/>
</dbReference>
<dbReference type="PIR" id="A94068">
<property type="entry name" value="EUHUGC"/>
</dbReference>
<dbReference type="PIR" id="I52980">
<property type="entry name" value="I52980"/>
</dbReference>
<dbReference type="PIR" id="I67792">
<property type="entry name" value="I67792"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000148.2">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_000157.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005741.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_001005741.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005742.1">
<molecule id="P04062-1"/>
<property type="nucleotide sequence ID" value="NM_001005742.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165282.1">
<molecule id="P04062-4"/>
<property type="nucleotide sequence ID" value="NM_001171811.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165283.1">
<molecule id="P04062-5"/>
<property type="nucleotide sequence ID" value="NM_001171812.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.282997"/>
<dbReference type="PDB" id="1OGS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="1Y7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2F61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2J25">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NSX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2NT1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2V3F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2VT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2WCG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2WKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2XWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="2XWE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.84"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3GXM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3KE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3KEH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=40-536"/>
</dbReference>
<dbReference type="PDB" id="3RIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="3RIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDB" id="5LVX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=40-536"/>
</dbReference>
<dbReference type="PDBsum" id="1OGS"/>
<dbReference type="PDBsum" id="1Y7V"/>
<dbReference type="PDBsum" id="2F61"/>
<dbReference type="PDBsum" id="2J25"/>
<dbReference type="PDBsum" id="2NSX"/>
<dbReference type="PDBsum" id="2NT0"/>
<dbReference type="PDBsum" id="2NT1"/>
<dbReference type="PDBsum" id="2V3D"/>
<dbReference type="PDBsum" id="2V3E"/>
<dbReference type="PDBsum" id="2V3F"/>
<dbReference type="PDBsum" id="2VT0"/>
<dbReference type="PDBsum" id="2WCG"/>
<dbReference type="PDBsum" id="2WKL"/>
<dbReference type="PDBsum" id="2XWD"/>
<dbReference type="PDBsum" id="2XWE"/>
<dbReference type="PDBsum" id="3GXD"/>
<dbReference type="PDBsum" id="3GXF"/>
<dbReference type="PDBsum" id="3GXI"/>
<dbReference type="PDBsum" id="3GXM"/>
<dbReference type="PDBsum" id="3KE0"/>
<dbReference type="PDBsum" id="3KEH"/>
<dbReference type="PDBsum" id="3RIK"/>
<dbReference type="PDBsum" id="3RIL"/>
<dbReference type="PDBsum" id="5LVX"/>
<dbReference type="ProteinModelPortal" id="P04062"/>
<dbReference type="SMR" id="P04062"/>
<dbReference type="BioGrid" id="108899">
<property type="interactions" value="48"/>
</dbReference>
<dbReference type="DIP" id="DIP-38645N"/>
<dbReference type="IntAct" id="P04062">
<property type="interactions" value="32"/>
</dbReference>
<dbReference type="MINT" id="MINT-3004354"/>
<dbReference type="STRING" id="9606.ENSP00000314508"/>
<dbReference type="BindingDB" id="P04062"/>
<dbReference type="ChEMBL" id="CHEMBL2179"/>
<dbReference type="DrugBank" id="DB03106">
<property type="generic name" value="Myo-Inositol"/>
</dbReference>
<dbReference type="DrugBank" id="DB03740">
<property type="generic name" value="N-acetyl-alpha-D-glucosamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06720">
<property type="generic name" value="Velaglucerase alfa"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001387"/>
<dbReference type="Allergome" id="8244">
<property type="allergen name" value="Hom s Glucocerebrosidase"/>
</dbReference>
<dbReference type="CAZy" id="GH30">
<property type="family name" value="Glycoside Hydrolase Family 30"/>
</dbReference>
<dbReference type="iPTMnet" id="P04062"/>
<dbReference type="PhosphoSitePlus" id="P04062"/>
<dbReference type="SwissPalm" id="P04062"/>
<dbReference type="BioMuta" id="GBA"/>
<dbReference type="DMDM" id="55584151"/>
<dbReference type="EPD" id="P04062"/>
<dbReference type="MaxQB" id="P04062"/>
<dbReference type="PaxDb" id="P04062"/>
<dbReference type="PeptideAtlas" id="P04062"/>
<dbReference type="PRIDE" id="P04062"/>
<dbReference type="DNASU" id="2629"/>
<dbReference type="Ensembl" id="ENST00000327247">
<molecule id="P04062-1"/>
<property type="protein sequence ID" value="ENSP00000314508"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368373">
<molecule id="P04062-1"/>
<property type="protein sequence ID" value="ENSP00000357357"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427500">
<molecule id="P04062-5"/>
<property type="protein sequence ID" value="ENSP00000402577"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000428024">
<molecule id="P04062-4"/>
<property type="protein sequence ID" value="ENSP00000397986"/>
<property type="gene ID" value="ENSG00000177628"/>
</dbReference>
<dbReference type="GeneID" id="2629"/>
<dbReference type="KEGG" id="hsa:2629"/>
<dbReference type="UCSC" id="uc001fjh.4">
<molecule id="P04062-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2629"/>
<dbReference type="DisGeNET" id="2629"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000177628.15"/>
<dbReference type="GeneCards" id="GBA"/>
<dbReference type="GeneReviews" id="GBA"/>
<dbReference type="H-InvDB" id="HIX0001123"/>
<dbReference type="HGNC" id="HGNC:4177">
<property type="gene designation" value="GBA"/>
</dbReference>
<dbReference type="HPA" id="CAB037171"/>
<dbReference type="HPA" id="CAB037289"/>
<dbReference type="HPA" id="HPA006667"/>
<dbReference type="MalaCards" id="GBA"/>
<dbReference type="MIM" id="168600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="230800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="230900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="231000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="231005">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606463">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608013">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04062"/>
<dbReference type="OpenTargets" id="ENSG00000177628"/>
<dbReference type="Orphanet" id="1648">
<property type="disease" value="Dementia with Lewy body"/>
</dbReference>
<dbReference type="Orphanet" id="85212">
<property type="disease" value="Fetal Gaucher disease"/>
</dbReference>
<dbReference type="Orphanet" id="2072">
<property type="disease" value="Gaucher disease - ophthalmoplegia - cardiovascular calcification"/>
</dbReference>
<dbReference type="Orphanet" id="77259">
<property type="disease" value="Gaucher disease type 1"/>
</dbReference>
<dbReference type="Orphanet" id="77260">
<property type="disease" value="Gaucher disease type 2"/>
</dbReference>
<dbReference type="Orphanet" id="77261">
<property type="disease" value="Gaucher disease type 3"/>
</dbReference>
<dbReference type="Orphanet" id="319705">
<property type="disease" value="Parkinson disease"/>
</dbReference>
<dbReference type="Orphanet" id="2828">
<property type="disease" value="Young adult-onset Parkinsonism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28591"/>
<dbReference type="eggNOG" id="KOG2566">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5520">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000009464"/>
<dbReference type="HOVERGEN" id="HBG002285"/>
<dbReference type="InParanoid" id="P04062"/>
<dbReference type="KO" id="K01201"/>
<dbReference type="OMA" id="TYCDSLD"/>
<dbReference type="OrthoDB" id="EOG091G06I4"/>
<dbReference type="PhylomeDB" id="P04062"/>
<dbReference type="TreeFam" id="TF314254"/>
<dbReference type="BRENDA" id="3.2.1.45">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660662">
<property type="pathway name" value="Glycosphingolipid metabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-390471">
<property type="pathway name" value="Association of TriC/CCT with target proteins during biosynthesis"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04062"/>
<dbReference type="GeneWiki" id="Glucocerebrosidase"/>
<dbReference type="GenomeRNAi" id="2629"/>
<dbReference type="PRO" id="PR:P04062"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000177628"/>
<dbReference type="CleanEx" id="HS_GBA"/>
<dbReference type="CleanEx" id="HS_GC"/>
<dbReference type="ExpressionAtlas" id="P04062">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04062">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004348">
<property type="term" value="F:glucosylceramidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905037">
<property type="term" value="P:autophagosome organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901805">
<property type="term" value="P:beta-glucoside catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009267">
<property type="term" value="P:cellular response to starvation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046513">
<property type="term" value="P:ceramide biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006680">
<property type="term" value="P:glucosylceramide catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006687">
<property type="term" value="P:glycosphingolipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032463">
<property type="term" value="P:negative regulation of protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904925">
<property type="term" value="P:positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904457">
<property type="term" value="P:positive regulation of neuronal action potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043243">
<property type="term" value="P:positive regulation of protein complex disassembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035307">
<property type="term" value="P:positive regulation of protein dephosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903061">
<property type="term" value="P:positive regulation of protein lipidation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051247">
<property type="term" value="P:positive regulation of protein metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903052">
<property type="term" value="P:positive regulation of proteolysis involved in cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032268">
<property type="term" value="P:regulation of cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905165">
<property type="term" value="P:regulation of lysosomal protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016241">
<property type="term" value="P:regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033561">
<property type="term" value="P:regulation of water loss via skin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071548">
<property type="term" value="P:response to dexamethasone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009268">
<property type="term" value="P:response to pH"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033574">
<property type="term" value="P:response to testosterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097066">
<property type="term" value="P:response to thyroid hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043589">
<property type="term" value="P:skin morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046512">
<property type="term" value="P:sphingosine biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0023021">
<property type="term" value="P:termination of signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR033452">
<property type="entry name" value="GH30_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001139">
<property type="entry name" value="Glyco_hydro_30"/>
</dbReference>
<dbReference type="InterPro" id="IPR033453">
<property type="entry name" value="Glyco_hydro_30_TIM-barrel"/>
</dbReference>
<dbReference type="InterPro" id="IPR017853">
<property type="entry name" value="Glycoside_hydrolase_SF"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11069">
<property type="entry name" value="PTHR11069"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02055">
<property type="entry name" value="Glyco_hydro_30"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17189">
<property type="entry name" value="Glyco_hydro_30C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00843">
<property type="entry name" value="GLHYDRLASE30"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51445">
<property type="entry name" value="SSF51445"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0307">Gaucher disease</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0326">Glycosidase</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0977">Ichthyosis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0582">Pharmaceutical</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0746">Sphingolipid metabolism</keyword>
<feature type="signal peptide" description="In isoform Long" evidence="69">
<location>
<begin position="1"/>
<end position="39"/>
</location>
</feature>
<feature type="signal peptide" description="In isoform Short" evidence="69">
<location>
<begin position="21"/>
<end position="39"/>
</location>
</feature>
<feature type="chain" description="Glucosylceramidase" id="PRO_0000012177">
<location>
<begin position="40"/>
<end position="536"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="25">
<location>
<position position="274"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="25">
<location>
<position position="379"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20 29">
<location>
<position position="58"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19 29 35">
<location>
<position position="98"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19 29">
<location>
<position position="185"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19 35">
<location>
<position position="309"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="501"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="43"/>
<end position="55"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025216" evidence="74">
<location>
<begin position="1"/>
<end position="161"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_054655" evidence="71">
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_018800" evidence="72 73">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_054656" evidence="71">
<location>
<begin position="103"/>
<end position="151"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025217" evidence="74">
<original>LA</original>
<variation>PS</variation>
<location>
<begin position="422"/>
<end position="423"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_025218" evidence="74">
<location>
<begin position="425"/>
<end position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease; dbSNP:rs142761046." id="VAR_063066" evidence="36">
<original>K</original>
<variation>E</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs121908302." id="VAR_003255" evidence="52">
<original>V</original>
<variation>L</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; neuronopathic and perinatal lethal forms; loss of activity; dbSNP:rs773007510." id="VAR_032394" evidence="17 23 28">
<original>C</original>
<variation>S</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity." id="VAR_032395" evidence="24">
<original>D</original>
<variation>N</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003256" evidence="60">
<original>F</original>
<variation>V</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In GD2." id="VAR_009033" evidence="68">
<original>E</original>
<variation>K</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs1141811." id="VAR_003257">
<original>T</original>
<variation>I</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs77829017." id="VAR_003258" evidence="52 60">
<original>G</original>
<variation>E</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 20% of normal activity; dbSNP:rs78769774." id="VAR_032197" evidence="28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs1141814." id="VAR_003259" evidence="15 58 60">
<original>R</original>
<variation>W</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1141815." id="VAR_032396">
<original>M</original>
<variation>T</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; 8% of normal activity; increases susceptibility to proteolytic degradation; dbSNP:rs121908312." id="VAR_003260" evidence="15 28">
<original>K</original>
<variation>N</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032397" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs758447515." id="VAR_009034" evidence="63">
<original>S</original>
<variation>L</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003261" evidence="64">
<original>G</original>
<variation>E</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032398" evidence="15">
<original>N</original>
<variation>D</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity; dbSNP:rs77834747." id="VAR_032399" evidence="24">
<original>I</original>
<variation>S</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003262">
<original>I</original>
<variation>T</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 13% of normal activity; dbSNP:rs79653797." id="VAR_003263" evidence="15 28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; dbSNP:rs439898." id="VAR_003264" evidence="15 24 60">
<original>R</original>
<variation>W</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 16% of normal activity; dbSNP:rs79637617." id="VAR_032198" evidence="28">
<original>P</original>
<variation>L</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs121908299." id="VAR_003265">
<original>P</original>
<variation>S</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation; dbSNP:rs377325220." id="VAR_032199" evidence="28">
<original>M</original>
<variation>V</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 9% of normal activity; increases susceptibility to proteolytic degradation; dbSNP:rs79796061." id="VAR_032200" evidence="28">
<original>D</original>
<variation>V</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1 and GD2; also found in a patient with Parkinson disease; dbSNP:rs398123530." id="VAR_009035" evidence="24 36 68">
<original>R</original>
<variation>C</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs80356763." id="VAR_009036" evidence="15">
<original>R</original>
<variation>L</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs78657146." id="VAR_032400" evidence="15">
<original>T</original>
<variation>I</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003266" evidence="12 64">
<original>T</original>
<variation>P</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs79660787." id="VAR_032401" evidence="16">
<original>A</original>
<variation>E</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs147138516." id="VAR_003267">
<original>D</original>
<variation>H</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; dbSNP:rs121908297." id="VAR_003268">
<original>K</original>
<variation>Q</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs80222298." id="VAR_009037" evidence="63">
<original>P</original>
<variation>L</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032402" evidence="18">
<original>P</original>
<variation>T</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity; dbSNP:rs77933015." id="VAR_032201" evidence="28">
<original>I</original>
<variation>N</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs77933015." id="VAR_010059">
<original>I</original>
<variation>S</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs76500263." id="VAR_032403" evidence="16">
<original>H</original>
<variation>P</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs398123532." id="VAR_032404" evidence="15">
<original>R</original>
<variation>C</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003269" evidence="15">
<original>R</original>
<variation>P</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 12% of normal activity; dbSNP:rs374591570." id="VAR_032202" evidence="28">
<original>L</original>
<variation>F</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003270" evidence="51">
<original>A</original>
<variation>D</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003271" evidence="43">
<original>P</original>
<variation>S</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity; dbSNP:rs80205046." id="VAR_032405" evidence="24">
<original>P</original>
<variation>L</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs866075757." id="VAR_003272" evidence="51">
<original>P</original>
<variation>T</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion; dbSNP:rs61748906." id="VAR_003273" evidence="48">
<original>W</original>
<variation>R</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 4% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032203" evidence="28">
<original>L</original>
<variation>F</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion; dbSNP:rs381418." id="VAR_003275">
<original>N</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs364897." id="VAR_003274" evidence="15 52 60">
<original>N</original>
<variation>S</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs78911246." id="VAR_010060" evidence="57">
<original>G</original>
<variation>V</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs75636769." id="VAR_009038">
<original>A</original>
<variation>E</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032406" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; very low activity; dbSNP:rs381427." id="VAR_032407" evidence="24">
<original>V</original>
<variation>E</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; gene conversion; dbSNP:rs381427." id="VAR_003276" evidence="8 48">
<original>V</original>
<variation>G</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; also found in a patient with Parkinson disease; 7% of normal activity." id="VAR_032204" evidence="28 36">
<original>G</original>
<variation>E</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; dbSNP:rs74462743." id="VAR_003277" evidence="58">
<original>G</original>
<variation>E</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009039" evidence="12">
<original>G</original>
<variation>W</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; gene conversion; dbSNP:rs1064644." id="VAR_003278" evidence="15 48">
<original>S</original>
<variation>P</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; loss of activity; increases susceptibility to proteolytic degradation; dbSNP:rs773409311." id="VAR_032205" evidence="16 28">
<original>K</original>
<variation>E</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs77451368." id="VAR_010061">
<original>G</original>
<variation>E</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type 2; gene conversion; dbSNP:rs409652." id="VAR_003279" evidence="11 15 18 24 48 51 58">
<original>G</original>
<variation>R</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs76026102." id="VAR_010062" evidence="11">
<original>Y</original>
<variation>C</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs121908300." id="VAR_003280">
<original>Y</original>
<variation>H</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; gene conversion; dbSNP:rs381737." id="VAR_003281" evidence="11 15 48 57 58 60">
<original>F</original>
<variation>I</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs74500255." id="VAR_003282" evidence="38">
<original>F</original>
<variation>Y</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs76725886." id="VAR_032408" evidence="18">
<original>T</original>
<variation>R</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003283">
<original>S</original>
<variation>P</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; perinatal lethal form; dbSNP:rs121908313." id="VAR_032409" evidence="16">
<original>F</original>
<variation>L</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; also found in Gaucher disease type 2; dbSNP:rs367968666." id="VAR_009040" evidence="24">
<original>H</original>
<variation>Q</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; also found in a patient with Parkinson disease; dbSNP:rs78973108." id="VAR_003284" evidence="15 36 51">
<original>R</original>
<variation>Q</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 4% of normal activity." id="VAR_009041" evidence="28 41">
<original>F</original>
<variation>L</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity." id="VAR_032206" evidence="28">
<original>L</original>
<variation>I</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs80116658." id="VAR_010063">
<original>G</original>
<variation>D</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs79215220." id="VAR_003285">
<original>P</original>
<variation>R</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057942." id="VAR_032410" evidence="48">
<original>S</original>
<variation>G</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; less than 5% of normal activity; dbSNP:rs74731340." id="VAR_010064" evidence="58">
<original>S</original>
<variation>N</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1; dbSNP:rs765633380." id="VAR_003286" evidence="15 24 51">
<original>R</original>
<variation>C</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs79696831." id="VAR_009042">
<original>R</original>
<variation>H</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs121908298." id="VAR_003287">
<original>P</original>
<variation>L</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs77714449." id="VAR_003288">
<original>K</original>
<variation>I</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; 16% of normal activity; increases susceptibility to proteolytic degradation; dbSNP:rs77321207." id="VAR_009043" evidence="28">
<original>Y</original>
<variation>C</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs78396650." id="VAR_003289">
<original>A</original>
<variation>V</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In perinatal lethal GD; dbSNP:rs78198234." id="VAR_009044" evidence="10">
<original>H</original>
<variation>R</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs121908304." id="VAR_003290">
<original>W</original>
<variation>C</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003291" evidence="53">
<original>Y</original>
<variation>H</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs398123526." id="VAR_003292">
<original>D</original>
<variation>H</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs78188205." id="VAR_003293">
<original>A</original>
<variation>D</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 6% of normal activity; dbSNP:rs76539814." id="VAR_003294" evidence="28">
<original>T</original>
<variation>I</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; unknown pathological significance." id="VAR_003295" evidence="40">
<original>L</original>
<variation>P</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs121908305." id="VAR_003296" evidence="48">
<original>G</original>
<variation>R</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; 42% of normal activity; dbSNP:rs2230288." id="VAR_003297" evidence="15 28">
<original>E</original>
<variation>K</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064648." id="VAR_032411" evidence="48">
<original>R</original>
<variation>H</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs781306264." id="VAR_009045" evidence="15 63">
<original>A</original>
<variation>T</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; loss of activity; dbSNP:rs121908306." id="VAR_003298" evidence="28">
<original>C</original>
<variation>G</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 12% of normal activity." id="VAR_032207" evidence="28">
<original>E</original>
<variation>K</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs398123527." id="VAR_010065" evidence="58">
<original>V</original>
<variation>L</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs121908308." id="VAR_010066" evidence="66">
<original>R</original>
<variation>G</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 5% of normal activity." id="VAR_032208" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs74979486." id="VAR_003299" evidence="53">
<original>R</original>
<variation>Q</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs149487315." id="VAR_032412" evidence="18">
<original>M</original>
<variation>I</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 8% of normal activity; increases susceptibility to proteolytic degradation; dbSNP:rs76228122." id="VAR_032209" evidence="28">
<original>Y</original>
<variation>C</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs121908307." id="VAR_003300">
<original>S</original>
<variation>T</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010067" evidence="57">
<original>S</original>
<variation>G</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009046" evidence="63">
<original>S</original>
<variation>N</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs75548401." id="VAR_003301" evidence="15 22">
<original>T</original>
<variation>M</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; common mutation; associated with susceptibility to Parkinson disease; alters interaction with saposin-C; mild; dbSNP:rs76763715." id="VAR_003302" evidence="8 9 12 15 24 26 28 34 36 39 42 46 55 58 70">
<original>N</original>
<variation>S</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 15% of normal activity; increases susceptibility to proteolytic degradation; dbSNP:rs121908314." id="VAR_032210" evidence="28">
<original>L</original>
<variation>V</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs398123528." id="VAR_010068" evidence="59">
<original>V</original>
<variation>L</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs121908311." id="VAR_003303" evidence="12 15">
<original>G</original>
<variation>S</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003304" evidence="51">
<original>W</original>
<variation>G</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; also found in a patient with Parkinson disease; dbSNP:rs77284004." id="VAR_003305" evidence="36">
<original>D</original>
<variation>A</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 4% of normal activity." id="VAR_032211" evidence="28">
<original>D</original>
<variation>H</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003306" evidence="51">
<original>D</original>
<variation>N</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 22% of normal activity." id="VAR_032212" evidence="28">
<original>N</original>
<variation>K</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs1057519357 and dbSNP:rs994723035." id="VAR_010069" evidence="55">
<original>P</original>
<variation>L</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_003307" evidence="64">
<original>G</original>
<variation>E</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 17% of normal activity." id="VAR_032213" evidence="28">
<original>G</original>
<variation>R</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs76910485." id="VAR_003308" evidence="64">
<original>P</original>
<variation>L</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs77738682." id="VAR_003309" evidence="64">
<original>N</original>
<variation>I</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_009047" evidence="63">
<original>W</original>
<variation>R</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; 12% of normal activity; dbSNP:rs80356769." id="VAR_003310" evidence="15 28 55">
<original>V</original>
<variation>L</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; mild; dbSNP:rs75385858." id="VAR_003311" evidence="54">
<original>N</original>
<variation>T</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 6% of normal activity; alters protein stability and increases susceptibility to proteolytic degradation; dbSNP:rs75243000." id="VAR_032214" evidence="28">
<original>F</original>
<variation>S</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In perinatal lethal GD; dbSNP:rs121908310." id="VAR_009048" evidence="10">
<original>V</original>
<variation>F</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In GD3." id="VAR_010070" evidence="50">
<original>V</original>
<variation>L</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type 2; 14% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_003312" evidence="24 28 47">
<original>D</original>
<variation>N</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_032413" evidence="15">
<original>D</original>
<variation>Y</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; dbSNP:rs74598136." id="VAR_010071" evidence="9 24">
<original>P</original>
<variation>L</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 3." id="VAR_032414" evidence="16">
<original>I</original>
<variation>F</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs75564605." id="VAR_010072" evidence="59">
<original>I</original>
<variation>T</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1 and type neuronopathic; at homozygosity it causes GD3C; also found in a patient with Parkinson disease; gene conversion; very low activity; alters protein stability; dbSNP:rs1064651." id="VAR_003313" evidence="11 12 15 17 24 28 36 42 56 57">
<original>D</original>
<variation>H</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; very low activity; alters protein stability; dbSNP:rs77369218." id="VAR_003314">
<original>D</original>
<variation>V</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010073">
<original>F</original>
<variation>I</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003315" evidence="64">
<original>Y</original>
<variation>H</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_010074" evidence="57">
<original>K</original>
<variation>Q</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2; dbSNP:rs121908295." id="VAR_003316">
<original>P</original>
<variation>R</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032215" evidence="28">
<original>M</original>
<variation>V</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003317">
<original>F</original>
<variation>V</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs74752878." id="VAR_003318" evidence="24 46">
<original>Y</original>
<variation>C</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1; associated with R-490; loss of activity." id="VAR_032415" evidence="24">
<original>G</original>
<variation>D</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe." id="VAR_003319">
<original>K</original>
<variation>E</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Parkinson disease; dbSNP:rs75671029." id="VAR_063067" evidence="36">
<original>D</original>
<variation>N</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In GD1 and GD2; common mutation; associated with susceptibility to Parkinson disease; gene conversion; very low activity; alters protein stability; dbSNP:rs421016." id="VAR_003321" evidence="11 12 15 24 28 36 42 55 57 60 68">
<original>L</original>
<variation>P</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; severe; dbSNP:rs421016." id="VAR_003320">
<original>L</original>
<variation>R</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In GD." id="VAR_003322">
<original>A</original>
<variation>P</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 1; associated with D-460; dbSNP:rs76071730." id="VAR_032416" evidence="18 24">
<original>H</original>
<variation>R</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; gene conversion; dbSNP:rs368060." id="VAR_003323" evidence="36">
<original>A</original>
<variation>P</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_063068" evidence="36">
<original>V</original>
<variation>L</variation>
<location>
<position position="497"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 10% of normal activity; increases susceptibility to proteolytic degradation." id="VAR_032216" evidence="28">
<original>L</original>
<variation>P</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; type 2." id="VAR_009049" evidence="61">
<original>N</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; 37% of normal activity; also found in patients with Parkinson disease; dbSNP:rs80356771." id="VAR_003324" evidence="15 36 37 42">
<original>R</original>
<variation>C</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; loss of activity; increases susceptibility to proteolytic degradation." id="VAR_032217" evidence="28">
<original>R</original>
<variation>P</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_003325">
<original>L</original>
<variation>P</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In GD2." id="VAR_009050" evidence="65">
<original>D</original>
<variation>Y</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; dbSNP:rs121908301." id="VAR_003326">
<original>G</original>
<variation>S</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In GD3; dbSNP:rs78016673." id="VAR_010075" evidence="50">
<original>T</original>
<variation>I</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs747506979." id="VAR_003327" evidence="57">
<original>R</original>
<variation>C</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="sequence variant" description="In GD; mild; dbSNP:rs75822236." id="VAR_003328" evidence="45">
<original>R</original>
<variation>H</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases activity 1000-fold." evidence="44">
<original>E</original>
<variation>G</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAH13357." ref="7" evidence="75">
<original>D</original>
<variation>G</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA02546." ref="5" evidence="75">
<original>N</original>
<variation>R</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 15; AA sequence." ref="15" evidence="75">
<original>S</original>
<variation>I</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35873." ref="1" evidence="75">
<original>R</original>
<variation>H</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="75"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="88"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="103"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="119"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="126"/>
<end position="133"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="137"/>
<end position="148"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="157"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="166"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="190"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="196"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="212"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="225"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="229"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="235"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="243"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="275"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="292"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="303"/>
<end position="308"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="315"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="324"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="329"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="338"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="346"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="359"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="373"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="386"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="396"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="414"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="426"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="440"/>
<end position="444"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="445"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="449"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="454"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="471"/>
<end position="479"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="482"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="495"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="507"/>
<end position="513"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="517"/>
<end position="523"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="527"/>
<end position="533"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OGS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J25"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NT0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GXF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GXI"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KEH"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10206680"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10340647"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10352942"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10360404"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10447266"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10744424"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10781797"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10796875"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11933202"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11992489"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12204005"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12792654"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12847165"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292921"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15605411"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15817452"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15826241"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16148263"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16293621"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17139081"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17187079"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17620502"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17897319"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18022370"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18332251"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19286695"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1972019"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1974409"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19846850"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26528954"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3001061"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7627184"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7627192"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7908905"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7916532"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8076951"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8112750"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8294033"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8432537"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8780099"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8790604"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8829654"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8829663"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8889591"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8937765"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9040001"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9061570"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9153297"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9182788"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9217217"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9279145"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9516376"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554454"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554746"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9637431"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9650766"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9683600"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9851895"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source ref="12"/>
</evidence>
<evidence key="70" type="ECO:0000269">
<source ref="14"/>
</evidence>
<evidence key="71" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3001061"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3864160"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8294033"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000305"/>
<sequence length="536" mass="59716" checksum="FA1E15684344A0E6" modified="2004-11-09" version="3" precursor="true">
MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNAT
YCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGF
GGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDD
FQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQP
GDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIA
RDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAK
ATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDW
NLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQK
NDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>